GloriaSHuangMD

PubMed

• Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
  Sangini S Sheth, Ji Eun Oh, Stefania Bellone, Eric R Siegel, Michelle Greenman, Levent Mutlu, Blair McNamara, Shefali Pathy, Mitchell Clark, Masoud Azodi, Gary Altwerg...> ;Clinical Cancer Research. 2024 Apr 9
• 3 citations
  Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
  Julia H Gelissen, Naomi N Adjei, Blair McNamara, Levent Mutlu, Justin A Harold, Mitchell Clark, Gary Altwerger, Peter R Dottino, Gloria S Huang, Alessandro D Santin, M...> ;Annals of Surgical Oncology. 2023 Sep 1
• 8 citations
  Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian car...
  Manavella, D., Dennis Mauricio, Stefania Bellone, Levent Mutlu, Blair McNamara, Diego D Manavella, Cem Demirkiran, Miguel Skyler Z Verzosa, Natalia Buza, Pei Hui, Tobi...> ;Gynecologic Oncology. 2023 Mar 1
• 2 citations
  Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
  Manavella, D., Diego D Manavella, Blair McNamara, Justin Harold, Stefania Bellone, Tobias Max Philipp Hartwich, Yang Yang-Hartwich, Levent Mutlu, Margherita Zipponi, C...> ;Gynecologic Oncology. 2023 Feb 1
• The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitr...
  Chanhee Han, Blair McNamara, Stefania Bellone, Justin Harold, Paola Manara, Tobias Max Philipp Hartwich, Levent Mutlu, Yang Yang-Hartwich, Margherita Zipponi, Cem Demi...> ;Gynecologic Oncology. 2023 Mar 1
• What role does adjuvant therapy play in the management of endometrial cancer?
  Gloria Shining Huang, Joan Tymon-Rosario, Alessandro D Santin> ;Expert Opinion on Pharmacotherapy. 2023 Jan 1
• 6 citations
  Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
  Manavella, D., Ghanshyam Yadav, Dana M Roque, Stefania Bellone, Diego D Manavella, Tobias M P Hartwich, Margherita Zipponi, Justin Harold, Joan Tymon-Rosario, Levent M...> ;Gynecologic Oncology. 2022 Aug 1
• 12 citations
  Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine dip...
  Manavella, D., Joan R Tymon-Rosario, Paola Manara, Diego D Manavella, Stefania Bellone, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipp...> ;Gynecologic Oncology. 2022 Jul 1
• 3 citations
  Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
  Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Masoud Azodi, Peter E Schwartz, Gautam G ...> ;British Journal of Cancer. 2022 Jun 1
• 27 citations
  A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
  Stefania Bellone, Dana M Roque, Eric R Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jungsoo Lee, Dan...> ;Cancer. 2022 Mar 15
• 2 citations
  Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer.
  Julia H Gelissen, Gloria S Huang> ;Frontiers in Oncology. 2022 Jan 1
• 3 citations
  Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy.
  Jessie Y. Li, Henry Park, Gloria S. Huang, Melissa R. Young, Elena Ratner, Alessandro D. Santin, Shari Damast> ;Gynecologic Oncology. 2021 Oct 1
• 7 citations
  DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
  Joan Tymon-Rosario, Elena Bonazzoli, Stefania Bellone, Aranzazu Manzano, Silvia Pelligra, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Burak Zeybek, Paola Manara...> ;Gynecologic Oncology. 2021 Nov 1
• 12 citations
  Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.
  Joan Tymon-Rosario, Eric R. Siegel, Stefania Bellone, Justin Harold, Naomi N Adjei, Burak Zeybek, Dennis Mauricio, Gary Altwerger, Gulden Menderes, Elena Ratner, Mitch...> ;Gynecologic Oncology. 2021 Oct 1
• 7 citations
  Financial toxicity in patients with gynecologic malignancies: a cross sectional study
  Burak Zeybek, Emily Webster, Natalia Pogosian, Joan Tymon-Rosario, Alan Balch, Gary Altwerger, Mitchell Clark, Gulden Menderes, Gloria S. Huang, Masoud Azodi, Elena Ra...> ;Journal of Gynecologic Oncology. 2021 Jul 23
• 26 citations
  A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated charact...
  Stefania Bellone, Dana M. Roque, Eric R. Siegel, Natalia Buza, Pei Hui, Elena Bonazzoli, Adele Guglielmi, Luca Zammataro, Nupur Nagarkatti, Samir Zaidi, Jung-Soo Lee, ...> ;Annals of Oncology. 2021 Apr 28
• 45 citations
  Integrated mutational landscape analysis of uterine leiomyosarcomas
  Jungmin Choi, Aranzazu Manzano, Weilai Dong, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Xiaotong Yao, Aditya Deshpande, Samir Zaidi, Adele Guglielmi, Barbara G...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Apr 13
• 5 citations
  Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer.
  Melissa A. Merritt, Howard D. Strickler, Alan D. Hutson, Mark H. Einstein, Thomas E. Rohan, Xiaonan Xue, Mark E. Sherman, Louise A. Brinton, Herbert Yu, David Miller, ...> ;Cancer Epidemiology, Biomarkers & Prevention. 2021 Feb 23
• 14 citations
  Population-Based Screening for Endometrial Cancer: Human vs. Machine Intelligence.
  Gregory R. Hart, Vanessa Yan, Gloria S. Huang, Ying Liang, Bradley J. Nartowt, Wazir Muhammad, Jun Deng> ;Frontiers in Artificial Intelligence. 2020 Nov 24
• 9 citations
  Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study.
  Emily Webster, Ghanshyam Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher Ke Arkfeld, Vaagn Andikyan, G...> ;Gynecologic Oncology Reports. 2020 Nov 2
• 2 citations
  Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
  Elena Bonazzoli, Stefania Bellone, Luca Zammataro, Barbara Gnutti, Adele Guglielmi, Silvia Pelligra, Nupur Nagarkatti, Paola Manara, Joan Tymon-Rosario, Burak Zeybek, ...> ;Gynecologic Oncology. 2020 Jun 26
• Stage III uterine serous carcinoma: modern trends in multimodality treatment.
  Jessie Y. Li, Melissa R. Young, Gloria S. Huang, Babak Litkouhi, Alessandro D. Santin, Peter E. Schwartz, Shari Damast> ;Journal of Gynecologic Oncology. 2020 May 25
• 17 citations
  Sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial aden...
  Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Ty...> ;Molecular Oncology. 2020 Mar 1
• 26 citations
  Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas.
  Salvatore Lopez, Emanuele Perrone, Stefania Bellone, Elena Bonazzoli, Burak Zeybek, Chanhee Han, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Anna Bianchi, Luc...> ;Oncotarget. 2020 Feb 4
• 15 citations
  In vitro and in vivo activity of sacituzumab govitecan, an antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (Trop-2) in uterine serous carcinoma.
  Chanhee Han, Emanuele Perrone, Burak Zeybek, Stefania Bellone, Joan Tymon-Rosario, Gary Altwerger, Gulden Menderes, Jacqueline Feinberg, Kaitlin Haines, Mariana Espina...> ;Gynecologic Oncology. 2020 Feb 1
• Join now to see all

Lectures

• Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group... 
  2019 ASCO Annual Meeting - 6/1/2019